51 results match your criteria: "Toronto Western Hospital UHN.[Affiliation]"
Alzheimers Dement
May 2024
Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Ontario, Canada.
Mov Disord Clin Pract
February 2024
Edmond J. Safra Program in Parkinson's Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital-UHN, Division of Neurology, University of Toronto, Toronto, Ontario, Canada.
Background: Functional parkinsonism is an important differential diagnosis of Parkinson's disease (PD). Based on anecdotal experience, we hypothesized that arm swing while walking and running could differentiate these two conditions, but this assumption has not been previously explored systematically.
Objectives: To examine differences in arm swing while walking and running between patients with PD and functional parkinsonism.
Mov Disord Clin Pract
November 2023
Edmond J. Safra Program in Parkinson's Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital-UHN, Division of Neurology, University of Toronto, Toronto, Ontario, Canada.
Background: Gait analysis objectively quantifies gait impairment in idiopathic normal pressure hydrocephalus (iNPH), may improve diagnosis and evaluation for surgical candidacy.
Objectives: This meta-analysis aims to understand which objective gait parameters improve after tap-test (TT) and CSF shunt surgery (CSS), also comparing responders (R) with non-responders (NR) and to assess if gait restores within the range of healthy controls after procedures.
Methods: Studies enrolling iNPH with at least one instrumented gait measure were selected.
J Int Neuropsychol Soc
December 2023
Krembil Brain Institute, Toronto Western Hospital UHN, Toronto, ON, Canada.
Objective: Subjective cognitive decline (SCD) and how much cognitive decline impacts one's ability to perform instrumental activities of daily living (iADLs) are necessary elements of neuropsychological assessment when diagnosing mild cognitive impairment (MCI) and dementia. Though limited, the literature suggests that culture and self-appraisal of cognitive abilities are related. However, it is unclear if differences exist in the subjective elements of neuropsychological assessments between patients born in Anglosphere countries (Canada, the USA, and the UK) versus immigrants born elsewhere (International Group).
View Article and Find Full Text PDFMov Disord Clin Pract
August 2023
Division of Neurology, Edmond J. Safra Program in Parkinson's Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital - UHN University of Toronto Toronto Ontario Canada.
Cancer Immunol Res
October 2023
Institute of Physiology, University of Zurich, Zurich, Switzerland.
The transcription factor c-Myb is overexpressed in many different types of solid tumors, including colorectal cancer. However, its exact role in tumorigenesis is unclear. In this study, we show that tumor-intrinsic c-Myb expression in mouse models of colon cancer and melanoma suppresses tumor growth.
View Article and Find Full Text PDFClin Neurophysiol
June 2023
Edmond J. Safra Program in Parkinson's Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital-UHN, Division of Neurology-University of Toronto, Toronto Canada.
The review provides a comprehensive update (previous report: Chen R, Cros D, Curra A, Di Lazzaro V, Lefaucheur JP, Magistris MR, et al. The clinical diagnostic utility of transcranial magnetic stimulation: report of an IFCN committee. Clin Neurophysiol 2008;119(3):504-32) on clinical diagnostic utility of transcranial magnetic stimulation (TMS) in neurological diseases.
View Article and Find Full Text PDFMov Disord Clin Pract
March 2023
Department of Internal Medicine, Movement Disorders Clinic, Neurology Service Federal University of Minas Gerais (UFMG) Belo Horizonte Brazil.
Background: The Parkinson's Disease-Cognitive Rating Scale (PD-CRS) assesses posterior-cortical and frontal-subcortical cognitive functioning and distinguishes mild cognitive impairment in Parkinson's disease (PD-MCI); however, it was not evaluated in Brazil.
Objectives: To investigate PD-CRS's reliability, validity, normative data, and accuracy for PD-MCI screening in Brazil.
Methods: The effects of age, education, and sex on PD-CRS scores were explored.
J Neurol
May 2023
Department of Neurology, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, Karnataka, India.
Background: While immediate benefits of levodopa-carbidopa intestinal gel (LCIG) are evident in patients with Parkinson's disease (PD), long-term LCIG effects require further study.
Objectives: We explored long-term LCIG on motor symptoms, nonmotor symptoms (NMS), and LCIG treatment settings in patients with advanced PD (APD).
Methods: Data were obtained (medical records and patient visit) from COSMOS, a multinational, retrospective, cross-sectional post-marketing observational study in patients with APD.
CMAJ
January 2023
Département de médecine familiale et communautaire (Jain), Centre des sciences de la santé Sunnybrook, Université de Toronto, Toronto, Ont.; Département des sciences cardiaques, Division de cardiologie (Stone), Faculté de médecine Cumming, Université de Calgary, Institut cardiovasculaire Libin de l'Alberta (Stone), Symphony of Health, Calgary, Alb.; Département de médecine familiale (Agarwal), Université McMaster, Hamilton, Ont.; Département de médecine (Andrade), Université de la Colombie-Britannique, Vancouver, C.-B.; Institut de cardiologie de Montréal (Andrade), Université de Montréal, Montréal, Qc; Bureau de la politique et de la promotion de la nutrition (Aziz), Santé Canada, Ottawa, Ont.; Département de Santé, Kinésiologie et Physiologie appliquée (Bacon), Université Concordia, et Centre de médecine comportementale de Montréal (Bacon), Centre intégré universitaire de santé et de services sociaux du Nord-de-l'Île-de-Montréal, Montréal, Qc; Centre de diabétologie Sinaï (Bajaj), Hôpital du Mont Sinaï; Département de psychiatrie (Baker), Université de Toronto, Toronto, Ont.; Centre de médecine familiale Herzl (Cheng), Hôpital général juif; Département de médecine familiale (Cheng), Université McGill; Hôpital général juif, Département de médecine (Dannenbaum), Université McGill, Montréal, Qc; Département de médecine familiale (Gelfer), Université de la Colombie-Britannique, Vancouver, C.-B.; Université de Toronto (Habert), Toronto, Ont.; Département de médecine familiale (Hickey), Hôpital régional St. Martha, Antigonish, N.-É.; Institut des politiques, de la gestion et de l'évaluation de la santé (Keshavjee), École Dalla Lana de santé publique, Université de Toronto, Toronto, Ont.; Faculté de médecine (Kitty), Université d'Ottawa, Ottawa, Ont.; Fondation canadienne des maladies du cœur et de l'AVC (Lindsay), Toronto, Ont.; Département des sciences de la nutrition (L'Abbé), Faculté de médecine Temerty, Université de Toronto, Toronto, Ont.; Département de biochimie et de biologie moléculaire (Lau), Université de Calgary, Calgary, Alb.; Institut de cardiologie de Montréal (Macle), Université de Montréal, Montréal, Qc; Division de cardiologie (McDonald), Centre de recherche en cardiologie Ted Rogers, Université de Toronto, Toronto, Ont.; Département de médecine (Nerenberg), Institut cardiovasculaire Libin, Université de Calgary, Calgary, Alb.; Division de cardiologie (Pearson), Institut de cardiologie Mazankowski; Université de l'Alberta, Faculté de médecine et de dentisterie (Pearson), Edmonton, Alb.; Division de néphrologie (Pham), Hôpital Sunnybrook, Université de Toronto, Toronto, Ont.; Division de neurologie (Poppe), Centre Hospitalier de l'Université de Montréal; Département de neurosciences (Poppe), Université de Montréal, Montréal, Qc; Division d'endocrinologie et métabolisme (Rabi), Département de médecine, Université de Calgary, Calgary, Alb.; Faculté des sciences infirmières (Sherifali), Université McMaster, Hamilton, Ont.; Centre pour les dépendances et la santé mentale (Selby); Département de médecine familiale et communautaire (Selby), Faculté de médecine Temerty, Université de Toronto, Toronto, Ont.; Département de neurosciences cliniques et Institut de neurologie Hotchkiss (Smith), Université de Calgary, Calgary, Alb.; Centre médical Argus en santé familiale (Stern), Oakville, Ont.; Services de santé Halton (Stern), Toronto, Ont.; Département de médecine (Thanassoulis), Université McGill, Montréal, Qc; Hôpital Humber River (Terenzi); Hôpital général de North York, Toronto Western Hospital-UHN, Université de Toronto (Tu); Maladies cardiovasculaires, Hôpital Women's College et Centre de cardiologie Peter Munk (Udell), Hôpital général de Toronto, Université de Toronto, Toronto, Ont.; Division de cardiologie (Virani), Université de la Colombie-Britannique; Faculté de l'éducation, programme pour la santé autochtone et l'activité physique (Warburton), Université de la Colombie-Britannique, Vancouver, C.-B.; Faculté de médecine Cumming (Ward), Université de Calgary, Calgary, Alb.; Faculté des sciences de la santé (Wharton), Université McMaster, Hamilton, Ont.; Health Sciences North (Zymantas); Faculté de médecine du Nord de l'Ontario (Zymantas), Sudbury, Ont.; Institut de recherche Sunnybrook (Hua-Stewart), Toronto, Ont.; Faculté de médecine (Liu), Institut de cardiologie de l'Université d'Ottawa, Ottawa, Ont.; Faculté de médecine (Liu), Université de Toronto; Division de néphrologie (Tobe), Centre des sciences de la santé Sunnybrook, Université de Toronto, Toronto, Ont.; Faculté de médecine du Nord de l'Ontario (Tobe), Sudbury, Ont.
CMAJ
November 2022
Department of Family and Community Medicine (Jain), Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ont.; Department of Cardiac Sciences, Division of Cardiology (Stone), Cumming School of Medicine University of Calgary, Libin Cardiovascular Institute of Alberta (Stone), Symphony of Health, Calgary, Alta.; Department of Family Medicine (Agarwal), McMaster University, Hamilton, Ont.; Department of Medicine (Andrade), University of British Columbia, Vancouver, BC; Montréal Heart Institute (Andrade), Université of Montréal, Que.; Office of Nutrition Policy Promotion (Aziz), Health Canada, Ottawa, Ont.; Department of Health, Kinesiology & Applied Physiology (Bacon), Concordia University, and the Montreal Behavioural Medicine Centre (Bacon), Centre intégré universitaire de santé et de services sociaux du Nord-de-l'Île-de-Montréal, Montréal, Que.; Sinai Centre for Diabetes (Bajaj), Mount Sinai Hospital; Department of Psychiatry (Baker), University of Toronto, Toronto, Ont.; Herzl Family Practice Centre (Cheng), Jewish General Hospital; Department of Family Medicine (Cheng), McGill University; Jewish General Hospital, Department of Medicine (Dannenbaum), McGill University, Montréal, Que.; Department of Family Practice (Gelfer), University of British Columbia, Vancouver, BC; University of Toronto (Habert), Toronto, Ont.; Department of Family Medicine (Hickey), St. Martha's Regional Hospital, Antigonish, NS; Institute of Health Policy, Management and Evaluation (Keshavjee), Dalla Lana School of Public Health, University of Toronto, Toronto, Ont.; Faculty of Medicine (Kitty), University of Ottawa, Ottawa, Ont.; Heart and Stroke Foundation of Canada (Lindsay), Toronto, Ont.; Department of Nutritional Sciences (L'Abbé), Temerty Faculty of Medicine, University of Toronto, Toronto, Ont.; Department of Biochemistry and Molecular Biology (Lau), University of Calgary, Calgary, Alta.; Institut de Cardiologie de Montréal (Macle), Université de Montréal, Montréal, Que.; Division of Cardiology (McDonald), Ted Rogers Centre for Heart Research, University of Toronto, Toronto, Ont.; Department of Medicine (Nerenberg), Libin Cardiovascular Institute, University of Calgary, Calgary, Alta.; Division of Cardiology (Pearson), Mazankowski Alberta Heart Institute; University of Alberta, Faculty of Medicine and Dentistry (Pearson), Edmonton, Alta.; Division of Nephrology (Pham), Sunnybrook Hospital, University of Toronto, Toronto, Ont.; Division of Neurology (Poppe), Centre Hospitalier de l'Université de Montréal; Department of Neurosciences (Poppe), Université de Montréal, Montréal, Que.; Division of Endocrinology and Metabolism (Rabi), Department of Medicine, University of Calgary, Calgary, Alta.; School of Nursing (Sherifali), McMaster University, Hamilton, Ont.; Centre for Addiction and Mental Health (Selby), Toronto, Ont.; Department of Family and Community Medicine (Selby), Temerty Faculty of Medicine, University of Toronto, Toront, Ont.; Department of Clinical Neurosciences and Hotchkiss Brain Institute (Smith), University of Calgary, Calgary, Alta.; Argus Medical Centre Family Health Organization (Stern), Oakville, Ont.; Halton Healthcare Services (Stern), Toronto, Ont.; Department of Medicine (Thanassoulis), McGill University, Montréal, Que.; Humber River Hospital (Terenzi), Toronto, Ont.; North York General Hospital, Toronto Western Hospital-UHN, University of Toronto (Tu), Toronto, Ont.; Cardiovascular Disease, Women's College Hospital and Peter Munk Cardiac Centre (Udell), Toronto General Hospital, University of Toronto, Toronto, Ont.; Division of Cardiology (Virani), University of British Columbia; Faculty of Education, Indigenous Health & Physical Activity Program (Warburton), University of British Columbia, Vancouver, BC; Cumming School of Medicine (Ward), University of Calgary, Calgary, Alta.; Faculty of Health Sciences (Wharton), McMaster University, Hamilton, Ont.; Health Sciences North (Zymantas); Northern Ontario School of Medicine (Zymantas), Sudbury, Ont.; Sunnybrook Research Institute (Hua-Stewart), Toronto, Ont.; Faculty of Medicine (Liu), University of Ottawa Heart Institute, Ottawa, Ont.; Faculty of Medicine (Liu), University of Toronto, Toronto, Ont.; Division of Nephrology (Tobe), Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ont.; Northern Ontario School of Medicine (Tobe), Sudbury, Ont.
Int Rev Neurobiol
October 2022
Edmond J. Safra Program in Parkinson's Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital-UHN, Division of Neurology, University of Toronto, Toronto, ON, Canada; Krembil Research Institute, Toronto, ON, Canada; Center for Advancing Neurotechnological Innovation to Application (CRANIA), Toronto, ON, Canada. Electronic address:
The global explosion of COVID-19 necessitated the rapid dissemination of information regarding SARS-CoV-2. Hence, COVID-19 prevalence and outcome data in Parkinson's disease patients were disseminated at a time when we only had part of the picture. In this chapter we firstly discuss the current literature on the prevalence of COVID-19 in people with PD.
View Article and Find Full Text PDFEur Spine J
February 2023
Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
Purpose: There is currently no consensus on the management of high-grade spondylolisthesis (HGS) in paediatric populations. The objective of this analysis is to compare the outcomes of reduction followed by fusion (RFF) or in situ fusion (ISF) in paediatric patients.
Methods: Using major databases, a systematic literature search was performed.
Rheumatol Ther
December 2022
Novartis Pharma AG, Fabrikstrasse 2, 4056, Basel, Switzerland.
Introduction: Sjögren's Syndrome Symptom Diary (SSSD) and Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) are patient-reported outcome (PRO) instruments assessing Sjögren's symptoms. Original SSSD items have demonstrated content validity, however qualitative evidence supporting the updated 'tiredness' item and two new supplementary items is lacking. Although well established and validated in other rheumatic diseases, there is no qualitative evidence supporting content validity of FACIT-F in Sjögren's.
View Article and Find Full Text PDFMov Disord Clin Pract
September 2022
Edmond J. Safra Program in Parkinson's Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital-UHN, Division of Neurology University of Toronto Toronto Ontario Canada.
Rheumatol Ther
December 2022
Novartis Pharma AG, Fabrikstrasse 2, 4056, Basel, Switzerland.
Introduction: European Alliance of Associations for Rheumatology (EULAR) Sjögren's Syndrome Disease Activity Index (ESSDAI) is a clinician-reported outcome (ClinRO) instrument, assessing Sjögren's disease activity from the physician perspective. EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI) is a patient-reported outcome (PRO) instrument, assessing patient-defined Sjögren's symptom severity. Both instruments are commonly used as clinical trial endpoints and have been psychometrically validated.
View Article and Find Full Text PDFAnn Neurol
November 2022
Edmond J. Safra Program in Parkinson's Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital-UHN, Division of Neurology, University of Toronto, Toronto, ON, Canada.
Mov Disord Clin Pract
April 2022
Edmond J. Safra Program in Parkinson's Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital-UHN, Division of Neurology University of Toronto Toronto Ontario Canada.
Mov Disord Clin Pract
April 2022
Edmond J. Safra Program in Parkinson's Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital-UHN, Division of Neurology University of Toronto Toronto Ontario Canada.
We selected several "imaging pearls" presented during the Movement Disorder Society (MDS) Video Challenge for this review. While the event, as implicated by its name, was video-centered, we would like to emphasize the important role of imaging in making the correct diagnosis. We divided this anthology into two parts: genetic and acquired disorders.
View Article and Find Full Text PDFNeuromodulation
December 2022
Department of Urology, Toronto Western Hospital (UHN), University of Toronto, Toronto, Canada.
Introduction: The massive spread of COVID-19 affected many aspects of medical and surgical services. Many patients with sacral neuromodulation (SNM) devices needed integrated follow-up and close communication regarding the programming of the device. In this study, we aimed to explore the effect of COVID-19 lockdown on patients with SNM devices.
View Article and Find Full Text PDFArq Neuropsiquiatr
July 2021
Universidade de São Paulo, Faculdade de Medicina, Departamento de Neurologia, Centro de Distúrbios do Movimento, São Paulo SP, Brazil.
Background: Noninvasive stimulation has been widely used in the past 30 years to study and treat a large number of neurological diseases, including movement disorders.
Objective: In this critical review, we illustrate the rationale for use of these techniques in movement disorders and summarize the best medical evidence based on the main clinical trials performed to date.
Methods: A nationally representative group of experts performed a comprehensive review of the literature in order to analyze the key clinical decision-making factors driving transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS) in movement disorders.
Background: The Montreal Cognitive Assessment (MoCA) and the Dementia Rating Scale-2 (DRS-2) are recommended screeners for Parkinson's disease mild cognitive impairment (PD-MCI). Cross-cultural studies examining their diagnostic precision have not addressed cultural bias in a multicultural setting.
Objectives: To compare DRS-2 and MoCA performance between patients born in Canada, the USA, and the UK (Anglosphere group) and immigrant patients born elsewhere (International group).
CJC Open
June 2021
Division of Neurology, Toronto Western Hospital-UHN, University of Toronto, Toronto, Ontario, Canada.
Background: Our original pilot study in 2008 demonstrated a poor degree of awareness of heart disease and stroke among Chinese Canadians, warranting an updated survey of their knowledge. We sought to determine the current degree of knowledge of cardiovascular disease, including stroke, among ethnic Chinese residents of Canada.
Methods: A 35-question online survey was conducted in the fall of 2017 among 1001 Chinese Canadians (aged ≥ 18 years) in the greater Toronto area (n = 501) and Vancouver (n = 500).
Neuropsychology
July 2021
Neuropsychology Clinic, Toronto Western Hospital UHN.
Reward-based decision-making is a growing area of research in Parkinson's disease (PD), a disorder characterized by alterations in dopamine and cortico-striatal circuits. While reward is typically operationalized as a gain, altruistic decisions also engage the reward system in fMRI studies. Although altruism comes at a cost, individuals may be motivated by the social reward associated with benefitting another.
View Article and Find Full Text PDF